4 Followers on Owler

Kiyatec

KIYATEC is a South Carolina-based cancer diagnostic company that offers services such as drug development and clinical testing to the healthcare and biotechnology sectors. Read more

Matthew R. Gevaert's photo - Co-Founder & CEO of Kiyatec

Co-Founder & CEO

Matthew R. Gevaert

CEO Approval Rating

90/100

Founded:

2005

Status:

PrivateIndependent Company

KIYATEC TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

InSphero is one of Kiyatec's top rivals. InSphero is a Private company that was founded in 2009 in Schlieren, Zurich. InSphero competes in the Biotechnology industry. Compared to Kiyatec, InSphero has 25 more employees.

Synthecon is seen as one of Kiyatec's biggest rivals. Synthecon was founded in 1990 in Houston, Texas. Synthecon is in the Biotechnology industry. Synthecon generates $2M less revenue than Kiyatec.

3D Biotek is one of Kiyatec's top competitors. 3D Biotek was founded in 2007, and its headquarters is in Bridgewater, New Jersey. 3D Biotek is in the Biotechnology field. 3D Biotek has 17 fewer employees than Kiyatec.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Spark Therapeutics a competitor of Kiyatec?

Kiyatec Acquisitions

No recent acquisitions found related to Kiyatec

Kiyatec Funding History

Since Kiyatec was founded in 2005, it has participated in 7 rounds of funding. In total Kiyatec has raised $14.3M. Kiyatec's last funding round was on Apr 2021 for a total of $2.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Venture Round
Apr 2021
$2.5M

Seae Ventures

Debt - PPP (CARES Act)
Apr 2020
$150K - $350K
Equity
Jan 2020
--
Series B
Apr 2019
$3M
Equity
Feb 2019
$5.3M
-

Since Kiyatec was founded in 2005, it has participated in 7 rounds of funding. In total Kiyatec has raised $14.3M. Kiyatec's last funding round was on Apr 2021 for a total of $2.5M

Kiyatec Investments

No recent investments found related to Kiyatec

Kiyatec News

March 24, 2021BioPharma-Reporter

KIYATEC flags checkpoint inhibitor response prediction milestone

US company, KIYATEC, says a new study has shown that its immune-modified ex vivo platform can measure... See more »
March 11, 2021MarketScreener

Checkpoint Inhibitor Response Prediction Milestone Achieved in KIYATEC Study Detecting Ex Vivo Cancer Patient-Specific Immune Response

(marketscreener.com) Predictive platform expansion into immunotherapy testing a boon for pharma today... See more »
April 1, 2020BioPortfolio

Cancer Diagnostics Innovator KIYATEC Expands Services to Help Relieve COVID19 Testing Bottleneck

Company making up to 71000 RNA extractions available to testing laboratoriesKIYATEC Inc. a clinicalst... See more »
March 2, 2020BioSpace

VA Portland Health Care System Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Glioblastoma Drugs

KIYATEC, Inc. today announced that VA Portland Health Care System (VAPORHCS) has joined the growing r... See more »
January 8, 2020VC News Daily

KIYATEC Secures Investment

GREENVILLE, SC, KIYATEC has secured an investment from life sciences venture investment company Esper... See more »
January 8, 2020BioPortfolio

KIYATEC Secures Investment from Life Sciences Venture Fund Esperante to Fuel Clinical Assay Validation Efforts

Agreement stems from National Cancer Institute Investor Initiatives programKIYATEC Inc. announced tod... See more »
November 18, 2019The Pharma Letter

BRIEF-CarThera and Kiyatec collaborate on personalized medicine for glioblastoma

US biotech Kiyatec and France's CarThera have entered into a clinical collaboration for the purpose..... See more »

Kiyatec Press Releases

February 6, 2019Business Wire

KIYATEC Adds Oregon Health & Science University as Study Site for Landmark Clinical Validation Trial of Test to Predict Response to Cancer Therapy Prior to Treatment

GREENVILLE, S.C.--(BUSINESS WIRE)--KIYATEC Adds Oregon Health & Science University to Clinical Trial ... See more »
April 12, 2016Business Wire

SCRA Portfolio Company KIYATEC Announces Inaugural Scientific Advisory Board Members

GREENVILLE, S.C.--(BUSINESS WIRE)--SCRA portfolio company KIYATEC announces members of its Scientific... See more »
November 11, 2015BUSINESS WIRE

SCRA Announces Investment in KIYATEC

SUMMERVILLE, S.C.--(BUSINESS WIRE)--SCRA invests in South Carolina-based cancer-diagnostic company KI... See more »
October 22, 2015BUSINESS WIRE

SCRA Technology Ventures Company KIYATEC Awarded $1.725M to Advance Cancer Stem Cell Expansion

GREENVILLE, S.C.--(BUSINESS WIRE)--SC Launch company KIYATEC awarded SBIR... See more »
June 16, 2014PR NEWSWIRE

KIYATEC recognized with spot in NIH "Innovation Zone"

GREENVILLE, S.C., June 16, 2014 /PRNewswire/ -- KIYATEC, a private company prioritizing the accurate ... See more »
April 3, 2014PRWEB

KIYATEC appoints Bob Silverman as Board Chairman

KIYATEC, a private company prioritizing the accurate ex vivo prediction of patient response to drug t... See more »

Social Media

Kiyatec Headquarters

900-B West Faris Road

Greenville, South Carolina29605

864-502-2013

Driving Directions »

Trending Companies

Kiyatec Summary

ABOUT

Overview

KIYATEC is a South Carolina-based cancer diagnostic company that offers services such as drug development and clinical testing to the healthcare and biotechnology sectors. Kiyatec was founded in 2005. Kiyatec's headquarters is located in Greenville, S...

CEO

Kiyatec's Co-Founder & CEO, Matthew R. Gevaert, currently has an approval rating of 90%. Kiyatec's primary competitors are InSphero, Synthecon & 3D Biotek.

Frequently Asked Questions about Kiyatec

  1. When was Kiyatec founded?

    Kiyatec was founded in 2005
  2. Who is Kiyatec's CEO?

    Kiyatec's CEO is Matthew R. Gevaert
  3. How much revenue does Kiyatec generate?

    Kiyatec generates $10M in revenue
  4. How much funding does Kiyatec have?

    Kiyatec has historically raised $14.3M in funding
  1. Where is Kiyatec's headquarters?

    Kiyatec's headquarters is in Greenville South Carolina, USA
  2. How many employees does Kiyatec have?

    Kiyatec has 35 employees
  3. What sector does Kiyatec operate in?

    Kiyatec is in Health Care Technology, Health Care Facilities
  4. Who are Kiyatec's competitors?

    Kiyatec's top competitors are InSphero, Synthecon, 3D Biotek